Cbio
Copenhagen, DK · 1 known investors
Find your way into Cbio
207 people in our graph share verified history with the Cbio team — schools, employers, funds. One of them is your warm intro.
Jesper Gromadaunlockedknows Jørgen Dam · together at Novo Nordisk (overlapped)
×5knows the team · via Novo Nordisk
×6knows the team · via DTU - Technical University of Denmark
Cbio develops next-generation T-cell therapies for solid tumors, which account for the majority of cancers. Its lead product, novoleucel, is a minimally invasive cell therapy designed to improve clinical outcomes and survival for late-stage cancer patients.
Founders & leadership
JD
Jørgen DaminCo-founder & Chief Operating OfficerJørgen Dam has management experience in R&D, manufacturing, and project management within biopharmaceuticals. He is founder of Cbio, which develops next-generation T-cell therapies for solid tumors.
Investors · 1
Frequently asked questions
- What does Cbio do?
- Cbio develops next-generation T-cell therapies for solid tumors, which account for the majority of cancers. Its lead product, novoleucel, is a minimally invasive cell therapy designed to improve clinical outcomes and survival for late-stage cancer patients.
- Who founded Cbio?
- Cbio was founded by Jørgen Dam.
- Who are Cbio's investors?
- Cbio's investors include Elmehøj Ventures.
- Where is Cbio headquartered?
- Cbio is headquartered in Copenhagen, DK.